CD8A and neoplasm: Furthermore, additional research indicates a positive correlation between TLS maturity and the level of CD8+ T-cell infiltration into the tumor mesenchyme, suggesting that tumors harboring mature TLS may benefit from immunotherapy owing to heightened infiltration of activated CD8+ T cells in the mesenchyme.